-
Cancer risks for MSH6 pathogenic variant carriers
Werf – ’t Lam, A.-S. V. D., Dowty, J. G., Italia, M., Bakker, A. C., Koops, F., Bleeker, F., Gomez – Garcia, E., van Hest, L. P., Gille, H. J. P., Cornips, C. C., de Jong, M. M., Letteboer, T. G. W., Duijkers, F. A. M., Wagner, A., Eikenboom, E. L., van Asperen, C. J., Bajwa – ten Broeke, S. W., Win, A. K., Jenkins, M. A. & Nielsen, M., 9 Dec 2025, In: Eur. J. Cancer. 231, 116098.Research output: Contribution to journal › Article › Academic › peer-review
-
Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients
Schei-Andersen, A. J., Schuurs-Hoeijmakers, J. H. M., van der Post, R., Mensenkamp, A. R., Schieving, J. & PTEN Study Group, Oct 2025, In: Clinical Genetics. 108, 4, p. 400-411 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased risk
Schei-Andersen, A. J., Witjes, V. M., Vos, J. R., Mensenkamp, A. R., van Altena, A., Schieving, J., Simons, M., Schuurs-Hoeijmakers, J. H. M. & PTEN Study Group, 1 Jun 2025, In: Familial Cancer. 24, 2, 28.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
